<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To determine the maturity of reticulocytes in patients with <z:hpo ids='HP_0001903'>anaemia</z:hpo> as a result of various <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> including those with qualitative abnormalities such as <z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo> or dyserythropoiesis </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The number of mature reticulocytes was measured with flow cytometry in venous blood samples from 122 patients with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> and 100 healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>Reticulocytes were classified into three categories by the fluorescence intensity of <z:chebi fb="0" ids="51876">auramin</z:chebi> O staining: low fluorescence ratio (LFR), medium fluorescence ratio (MFR), and high fluorescence ratio (HFR) </plain></SENT>
<SENT sid="3" pm="."><plain>Immature reticulocytes were determined as the aggregate of MFR and HFR (%) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The mean (2SD) number of immature reticulocytes in 100 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects was 9.0 (7.0)% </plain></SENT>
<SENT sid="5" pm="."><plain>Significantly high mean values of immature reticulocytes with a <z:mpath ids='MPATH_458'>normal</z:mpath> or reduced reticulocyte count were shown in 90 patients with dyserythropoietic or ineffective erythropoietic conditions, such as <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) (n = 37), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) (n = 35), aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> (AA) (n = 8), or <z:e sem="disease" ids="C0002888" disease_type="Disease or Syndrome" abbrv="">megaloblastic</z:e> <z:hpo ids='HP_0001903'>anaemia</z:hpo> (MA), (n = 6) </plain></SENT>
<SENT sid="6" pm="."><plain>Reticulocyte ratios returned to <z:mpath ids='MPATH_458'>normal</z:mpath> after successful treatment of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (n = 10) and MA (n = 3) </plain></SENT>
<SENT sid="7" pm="."><plain>However, high percentages of immature reticulocytes with <z:hpo ids='HP_0001923'>increased reticulocyte counts</z:hpo> were consistently observed in patients with enhanced erythropoiesis such as those with acquired <z:hpo ids='HP_0001890'>autoimmune haemolytic anaemias</z:hpo> (AIHA) (n = 4) or <z:hpo ids='HP_0011009'>acute</z:hpo> blood loss (ABL) (n = 4) </plain></SENT>
<SENT sid="8" pm="."><plain>Reticulocyte maturity was within the <z:mpath ids='MPATH_458'>normal</z:mpath> range in patients with reduced erythropoiesis such as occurs in <z:hpo ids='HP_0003774'>chronic renal failure</z:hpo> (CRF) (n = 11), or in <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> <z:hpo ids='HP_0001903'>anaemia</z:hpo> (IDA) (n = 13) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The evaluation of reticulocyte maturity with total reticulocyte count seems to be clinically useful for estimating the qualitative impairment of erythropoiesis, and so could help differentiate <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> </plain></SENT>
</text></document>